For research use only. Not for therapeutic Use.
3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].
| Catalog Number | I019488 |
| CAS Number | 2140-64-9 |
| Synonyms | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one |
| Molecular Formula | C10H15N3O5 |
| Purity | ≥95% |
| InChI | InChI=1S/C10H15N3O5/c1-12-6(11)2-3-13(10(12)17)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,11,14-16H,4H2,1H3/t5-,7-,8-,9-/m1/s1 |
| InChIKey | RDPUKVRQKWBSPK-ZOQUXTDFSA-N |
| SMILES | CN1C(=N)C=CN(C1=O)C2C(C(C(O2)CO)O)O |
| Reference | [1]. Hsu WY, et al. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. PLoS One. 2013 Dec 19;8(12):e81701. |
